
### [NCIT:C2948](http://purl.obolibrary.org/obo/NCIT_C2948)
**Label:** Choriocarcinoma

**Subclasses:** [NCIT:C4646](http://purl.obolibrary.org/obo/NCIT_C4646) (Gestational Choriocarcinoma), [NCIT:C4515](http://purl.obolibrary.org/obo/NCIT_C4515) (Ovarian Choriocarcinoma), [NCIT:C7733](http://purl.obolibrary.org/obo/NCIT_C7733) (Testicular Choriocarcinoma), [NCIT:C8733](http://purl.obolibrary.org/obo/NCIT_C8733) (Stage IV Ovarian Choriocarcinoma), [NCIT:C8731](http://purl.obolibrary.org/obo/NCIT_C8731) (Stage II Ovarian Choriocarcinoma), [NCIT:C8732](http://purl.obolibrary.org/obo/NCIT_C8732) (Stage III Ovarian Choriocarcinoma), [NCIT:C5793](http://purl.obolibrary.org/obo/NCIT_C5793) (Adult Central Nervous System Choriocarcinoma), [NCIT:C6278](http://purl.obolibrary.org/obo/NCIT_C6278) (Fallopian Tube Gestational Choriocarcinoma), [NCIT:C8730](http://purl.obolibrary.org/obo/NCIT_C8730) (Stage I Ovarian Choriocarcinoma), [NCIT:C5381](http://purl.obolibrary.org/obo/NCIT_C5381) (Pulmonary Artery Choriocarcinoma), [NCIT:C7012](http://purl.obolibrary.org/obo/NCIT_C7012) (Central Nervous System Choriocarcinoma), [NCIT:C95749](http://purl.obolibrary.org/obo/NCIT_C95749) (Gastric Choriocarcinoma), [NCIT:C40442](http://purl.obolibrary.org/obo/NCIT_C40442) (Gestational Ovarian Choriocarcinoma), [NCIT:C39991](http://purl.obolibrary.org/obo/NCIT_C39991) (Non-Gestational Ovarian Choriocarcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C68658](http://purl.obolibrary.org/obo/NCIT_C68658) (Malignant Trophoblastic Cell) 75.00%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C36803](http://purl.obolibrary.org/obo/NCIT_C36803) (Neoplastic Trophoblastic Cell) 75.00%
- [NCIT:C61405](http://purl.obolibrary.org/obo/NCIT_C61405) (Malignant Intermediate Type Trophoblastic Cell) 58.33%
- [NCIT:C54119](http://purl.obolibrary.org/obo/NCIT_C54119) (Malignant Syncytiotrophoblastic Giant Cell) 58.33%
- [NCIT:C54118](http://purl.obolibrary.org/obo/NCIT_C54118) (Malignant Cytotrophoblastic Cell) 58.33%
- [NCIT:C37142](http://purl.obolibrary.org/obo/NCIT_C37142) (Neoplastic Intermediate Type Trophoblastic Cell) and [NCIT:C68658](http://purl.obolibrary.org/obo/NCIT_C68658) (Malignant Trophoblastic Cell) 58.33%
- [NCIT:C37140](http://purl.obolibrary.org/obo/NCIT_C37140) (Neoplastic Cytotrophoblastic Cell) and [NCIT:C68658](http://purl.obolibrary.org/obo/NCIT_C68658) (Malignant Trophoblastic Cell) 58.33%
- [NCIT:C36906](http://purl.obolibrary.org/obo/NCIT_C36906) (Neoplastic Syncytiotrophoblastic Cell) and [NCIT:C68658](http://purl.obolibrary.org/obo/NCIT_C68658) (Malignant Trophoblastic Cell) 58.33%
- [NCIT:C36802](http://purl.obolibrary.org/obo/NCIT_C36802) (Abnormal Intermediate Type Trophoblastic Cell) and [NCIT:C68658](http://purl.obolibrary.org/obo/NCIT_C68658) (Malignant Trophoblastic Cell) 58.33%
- [NCIT:C36801](http://purl.obolibrary.org/obo/NCIT_C36801) (Abnormal Cytotrophoblastic Cell) and [NCIT:C68658](http://purl.obolibrary.org/obo/NCIT_C68658) (Malignant Trophoblastic Cell) 58.33%
- [NCIT:C36800](http://purl.obolibrary.org/obo/NCIT_C36800) (Abnormal Syncytiotrophoblastic Cell) and [NCIT:C68658](http://purl.obolibrary.org/obo/NCIT_C68658) (Malignant Trophoblastic Cell) 58.33%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C37142](http://purl.obolibrary.org/obo/NCIT_C37142) (Neoplastic Intermediate Type Trophoblastic Cell) 58.33%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C37140](http://purl.obolibrary.org/obo/NCIT_C37140) (Neoplastic Cytotrophoblastic Cell) 58.33%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C36906](http://purl.obolibrary.org/obo/NCIT_C36906) (Neoplastic Syncytiotrophoblastic Cell) 58.33%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C36802](http://purl.obolibrary.org/obo/NCIT_C36802) (Abnormal Intermediate Type Trophoblastic Cell) 58.33%


